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INTRODUCTION 
 Stone disease of the urinary tract is common, and many forms of treatment has 
been in vogue. Until early eighties open surgery and other endoscopic techniques 
were the treatment modalities available for urolithiasis
1
.
 
 Extracorporeal shock 
waves lithotripsy (ESWL) was introduced by Christian Chaussay in 1980. Since 
the mid 1980’s ESWL has been established as a minimally invasive procedure for 
a wide indications of urinary stones .  This revolutionized the management of the 
stone disease throughout the world .  
ESWL is a safe, effective method to treat urinary lithiasis. ESWL is usually an 
outpatient procedure.  The success rate in ESWL depends on stone location, size, 
number, and fragility as well as calyceal anatomy  and  patency of  the   
 urinary tract . 
 ESWL as a modality was recommended for stones less than 2 cm in size. This 
limit was set in view of high treatment failures and steinstrasse for bigger calculi
2
. 
Comparing with surgical techniques ESWL only fragments the stone and does not 
completely remove them from the urinary tract. These fragments should then be 
passed out spontaneously
3
. The duration for this spontaneous passage varies and  
the fragments may cause obstruction to the ureter, leading to complications such as   
hydronephrosis, renal colic and renal failure
 
.
 
The use of Double -J stents has 
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contributed to successful stone passage and reduced post ESWL morbidity . Hence 
the double–J–ureteric stent may be used in those patients having stones larger than 
2.5cm
4
. 
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AIMS AND OBJECTIVES  
To study the success rate of ESWL in treatment of upper urinary tract 
stones measuring less than 2cm. 
 
To study the various factors influencing the outcome of ESWL   in 
upper urinary tract stones 
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REVIEW OF LITERATURE 
The prevalence of stone disease is very high in most parts of India because of its 
geography, dietary habits, temperature and humidity superimposed on their 
intrinsic factors predisposing to stone formation. 
 Prevalence of stone disease is 1-15%. It varies by age, sex and race. For men, 
incidence begins to rise after age 20, peaks between 40 and 60 years and then 
begin to decline. For women incidence rates seem to be higher in late 20s and then 
decreasing to 1/1000/year at the age of 50. The incidence and prevalence of stone 
disease is increasing in recent years, may be due to increased detection of 
asymptomatic stones discovered with the greater use and higher sensitivity of 
imaging studies. 
Calcium is the most common component of urinary stones comprising about 75% 
of all stones. Calcium oxalate forms approximately 60%, mixed calcium oxalate 
and hydroxyapatite form 20% and brushite stones form 2%. Uric acid and 
Magnesium Ammonium Phosphate (Struvite)  stones occur in 10%. Cystine stones 
are rare comprising around 1%.  
                 Stone disease can be easily diagnosed using imaging studies like X-ray 
KUB, USG KUB, IVU and CT KUB.  
Plain radiography detects radio opaque calculi. The limitations are bowel gas, bone 
shadow overlapping the stones, and radiolucent stones.  
16 
 
USG KUB can detect calculi in the renal area and associated obstruction and 
dilatation of pelvi calyceal system. Limitations are obesity, bowel gas and poor 
sensitivity for ureteric calculi. 
IVU provides both anatomical and functional details. IVU helps in assessing the 
Infundibulo- pelvic angle and Infundibular width in lower pole stones. 
Disadvantage being the risk of contrast allergy and contrast induced nephropathy.  
Non contrast CT KUB is a simple method to detect renal and ureteric calculi, it 
helps to assess stone burden , stone density and dilatation of pelvicalyceal system, 
particularly during an episode of acute colic. 
 
Course of Untreated stones 
Stones in the calyces
9 
In the past due to high complications associated with open surgery, urologists were 
hesitant to remove asymptomatic stones or stones with minimum symptoms. 
Traditionally considered indications for the management of a calculus in the renal 
collecting system include obstruction, pain and infection. This holds true even in 
todays modern set up. Pin hole surgeries with minimal morbidity to the patients  
has allowed to expand the indication for treatment to patients with asymptomatic 
large stones. To decide for intervention a thorough understanding of the natural 
course of untreated calyceal stones is necessary.  
17 
 
Hubner and Porpaczy (1990) in their study analyzed the natural history of stones in 
the calyx  and followed the patients for a an average period of 7.4 years.  In 45% of 
patients the stone size increased, 68% patients developed infection and pain was 
experienced by 51% of the patients
10
.
 
 
Inci and associates (2007) in their study found that in patients with lower pole 
calculi that are asymptomatic, 1/3
rd
 of the stones progressively increased in size 
and 11% finally underwent a surgical procedure. Most calyceal stones if left alone 
without any treatment increase in size and develop symptoms of infection and 
pain
11
.
 
 
Reviewing the literature, evidence for treating small (<5mm) stones that are 
asymptomatic and non obstructive is still lacking. If asymptomatic stones are not 
treated, advice must be given regarding the necessity for regular follow-up visits 
because a large fraction of these calculi finally become symptomatic requiring 
treatment. Decisions regarding management in such conditions should consider the  
patient’s individual risk factors and the preference of the patient.  
In pediatric patients, high-risk professionals like pilots, solitary kidney status and 
women in the reproductive age group contemplating pregnancy, asymptomatic 
calyceal stones may be considered for treatment.  
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Factors related to the stone
 
Stone size, number, volume of stone, composition of the stone and location of the 
stone within the kidney influence the indications for treatment.  
Stone Burden influencing treatment
9 
Size and number of the stone form the most important factor in influencing the 
decision for the various treatment modalities in patients with renal calculi. Various 
criteria for size of the stone that would decide the treatment modality whether 
ESWL or other surgical procedures have been used in previous studies and 
guidelines. At present renal stones are classified into nonstaghorn and staghorn 
stones. Controversies regarding surgical treatment mainly arise while managing 
nonstaghorn stones.  
Clayman and associates
 
(1989) 
12
in their study concluded that while comparing the 
results of various treatment modalities like ESWL and PCNL, or while comparing 
the lithotripsy methods, parameters such as stone-free rate, number of auxiliary 
procedures and re-treatment rate should be combined to form an effectiveness 
quotient. This quotient express treatment results better and allow comparison of 
different modalities of treatment. 
 The present principle of ESWL is that as stone burden has an inverse relationship 
with stone free rate, the need for re-treatment and ancillary procedures increases 
with stone size. Stone burden is not based only on the basis of the largest stone size 
19 
 
but also the total number of stones present. PCNL is more invasive and is 
associated with increased morbidity. But stone-free rates following PCNL are 
better than ESWL and are not influenced by the size of the stone (Lingeman et al, 
1987)
13
. Ureteroscopy is another treatment modality with limitations of its use 
being the stone size and overall burden. The stone fragments are either fragmented 
and removed or vaporized using laser. With a large stone burden, PCNL has a 
better efficiency in clearing stones when compared to both ESWL or ureteroscopy.  
Nearly 50% to 60% of  renal stones that are single are less than 10 mm in diameter 
(Cass, 1995
14
; Renner and Rassweile
15
, 1999; Logarakis et al
16
, 2000). ESWL in 
these patients is overall satisfactory and is not dependent on stone location or 
composition.  
Patients with stones ranging between 10 and 20 mm are treated oftenly with ESWL 
as the first-line management. The location and composition of the stone influence 
the results of ESWL in patients with stones within this size range. The results for  
ESWL in patients with 10- 20 mm stones in the lower pole are far less (55%)  than 
those in the upper and middle pole calyces (71.8% and 76.5%, respectively) (Saw 
and Lingeman 
17
, 1999).  
Composition of the stone is an important  factor while deciding the various 
alternatives for treatment in patients with stones >10 mm, as calculi containing 
Cystine or Brushite respond less to ESWL treatment. This effect is significant for 
20 
 
stones larger than 15 to 20 mm. Patients with kidney stones between 10- 20 mm 
with risk factors predicting poor outcome of treatment with ESWL should be 
counselled regarding other therapeutic modalities. Both PCNL and ureteroscopy 
are less significantly influenced by location of the stone and composition and 
satisfactory results can be obtained with these procedures in patients with stones 
measuring 10-20 mm. 
Poor outcomes following ESWL as monotherapy are seen in patients with renal 
stones >2 cm. This was recognized nearly 20 years back in an NIH Consensus 
Conference. The 2 cm cut-off for ESWL first mentioned in this conference still 
holds good in present day scenarios (Consensus Conference, 1988).  
Ureteroscopy, as an alternative to ESWL for large stone burden emerged in the 
1990s as a considerable treatment option. Grasso and associates
18 
(1998) first 
published in their series, patients with large (>2 cm) upper urinary tract stones 
treated by ureteroscopy. 1/3rd of patients with stones in the kidney required a re-
look endoscopy; and three patients were converted to PCNL. The overall success 
rate was defined as fragmentation of the stone to size smaller than 2 mm and in this 
study it was 91% after the second ureteroscopy procedure, which was comparable 
to PCNL results. 6-month follow-up data was recorded in 25 patients and 
demonstrated only 60% stone free rates. In 24% residual lower pole fragments was 
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seen and in 16% patients there was growth of new stones. With improvements in  
surgical techniques and innovative technologies, ureteroscopy has been used to 
 treat patients with larger stone burdens with acceptable outcome results and 
morbidity. But these treatment approaches have often resorted to a staged approach 
to achieve a successful outcome. 
 
Stone Composition determining treatment modality
9 
Stone fragility was first described by Dretler
19
 in 1988. It was defined as the 
readiness with which a stone is fragmented by SWL and varies with stones of 
different composition. 
When adjusted for size, cystine and brushite calculi were the most resistant to 
SWL followed by calcium oxalate monohydrate as reported by Saw and 
Lingeman
17
 in 1999. Other stones in descending order of resistance to 
fragmentation are struvite > calcium oxalate dehydrate > uric acid stones. 
 The type of fragments produced is also influenced by the stone composition. 
Cystine and calcium oxalate monohydrate result in large pieces that are difficult to 
clear from the collecting system ( Rutchik and Resnick
20
, 1998). Patients with 
stones like brushite, cystine or calcium oxalate monohydrate should be treated by 
ESWL only if the stone size is <1.5 cm. Patients with bigger stones should 
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preferentially undergo PCNL or ureteroscopy. The outcome of various modalities 
of intracorporeal lithotripsy is also affected by the stone composition. 
Non–contrast-enhanced spiral CT is the most commonly utilized method of 
investigating patients with suspected renal colic at present. It is also useful to 
identify the stone composition utilizing the Hounsfield units of the stone. Several 
reports have been published using this investigative technology.  
Mostafavi and associates
21
 (1998) were the first to conduct an in-vitro study which 
utilized the attenuation levels calculated by CT to predict the chemical composition 
of the urinary tract calculi.  
Saw and associates
22
 in 2000 also reported that CT was useful to differentiate 
between stone groups ( with each stone containing a minimum of 60% of a single 
stone composition) on the basis of absolute attenuation values.  
Joseph and associates
23
 in 2002 reported that outcome of ESWL was significantly 
lower for those calculi with attenuation values > 1000 Hounsfield units (HU) when 
compared with those stones with attenuation values < 1000 HU.  
 
Renal Anatomic Factors
 
Anatomic factors whether congenital or acquired have been shown to influence the 
rate of stone clearance following ESWL. Congenital anomalies are relatively 
common in the upper urinary tract and the majority of defects affecting the 
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drainage of the collecting system are associated with an increased incidence of 
stone disease. Examples of congenital abnormalities include ureteropelvic junction 
(UPJ) obstruction, horseshoe kidney, calyceal diverticula and other ectopic or 
fusion anomalies. Hydronephrosis due to distal obstruction leads to a failure to 
clear stone fragments after SWL. The lower pole calyces have a dependent position 
and hence this affects the stone clearance rate after SWL. Hence any patient with 
distal obstruction should not undergo ESWL treatment. In the presence of 
concurrent obstruction and infection, ESWL results in life-threatening urosepsis. 
Patient is very unlikely to clear fragments of the stone unless the distal obstruction 
is relieved. 
 
Calculi in lower pole of kidney
 
Considerable controversy exists regarding the treatment of patients with renal 
calculi in the lower pole. Lingeman and associates
24
 (1994) in a meta analytical 
study first reported the drawbacks of ESWL for treatment of patients with lower 
pole stones. The study reported that the stone-free outcome achieved with PCNL 
was superior to that of ESWL (90% and 60% respectively).  Since the 1980s, a 
considerable change in the distribution of renal stones has been noted. There has 
been an increase in the percentage of ESWL  being used to treat patients with 
lower calyceal stones (2% in 1984 to 48% in 1991) (Lingeman et al
24
, 1994).  
24 
 
       Carr et al
25
, 1996 concluded that change in stone distribution can be explained 
on the aspect of minute radiographically undetectable fragments to gravitate to 
more dependent calyces after SWL therapy and to act as a nidus for new stone 
growth . But  the factors resulting in an unsuccessful  clearance of fragments from 
the lower pole after SWL are unclear. This gravity-dependent position of the lower 
pole calyx can impede  the passage of stone fragments (Elbahnasy et al
26 
, 1998b). 
 Sampaio and Aragao
27
 (1992 ) first described the anatomic factors. 
They concluded that a lower pole having multiple infundibula will have poor 
drainage .This will result  in a  lesser chance of the clearance of residual stone 
fragments than that of  an inferior pole drained by a single infundibulum receiving 
fused calyces. Also they concluded that the  small diameter of the lower pole 
infundibulum might hinder passage of stone fragments. They studied the angle 
formed between the lower infundibulum and the renal pelvis and hypothesized that  
an obtuse angle ( greater than 90 degrees ) will facilitate  better drainage of 
fragments from the lower pole.  
      Even with a poorer outcome of SWL treatment for lower pole calculi , a 
number of  urologists advocate this therapy. A survey  among urologists performed 
by Gerber  in 2003 found that 65% of urologists would prefer SWL for lower pole 
stones 1 to 2 cm in size .  2%  of urologists will advice  SWL to  treat stones 
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greater than 2 cm . But the success rates are generally poorer for SWL of lower 
pole calculi. 
      Albala and associates
28
  in 2001 performed a multicenter, randomized, 
prospective study  that compared PCNL or SWL as the treatment options  for 
patients with lower pole calculi.. The stone-free rate at 3 months after treatment, as 
calculated by nephrotomograms, was  37% for those undergoing SWL and  95% 
for those undergoing PCNL. Significanyly , stone clearance from the lower pole 
after SWL was especially poor as stone size increased above 10 mm. The main 
advantage was the lower morbidity associated with SWL. 
The Lower Pole Stone Study Group  which compared ureteroscopy and PCNL for 
patients with 10- to 25-mm lower pole stones (Kuo et al, 2003a
59
) concluded that 
the results of the study favored PNL, which had a 100% stone-free rate,as 
compared to   80% stone free  rate for ureteroscopy.  
      The optimal approach for treatment of lower pole stones continues to evolve 
even today. SWL is a good option for  lower pole stones of 1 cm or less in 
aggregate size since  there is a considerable chance of achieving a stone-free state 
with minimal  morbidity. Patients with lower pole stones of  2 cm or more are best 
served with PCNL because this offers them the ideal chance for stone clearance as 
a single procedure. The real  controversy lies  in treatment of lower pole calculi  10 
to 20 mm in diameter. PCNL, SWL and ureteroscopy are all acceptable options. 
26 
 
Factors to be considered before  recommending a treatment modality for these 
patients includes Stone composition and lower pole anatomy. Patients whose SWL 
treatment has failed, patients known to have stones resistant to SWL and Patients 
with an acute lower pole infundibulopelvic angle (with or without other 
unfavorable anatomic features) should be treated with PCNL or ureteroscopy.  
Clinical Factors
 
All coexisting clinical factors which  may affect the safety and the efficacy of the 
selected treatment must be considered. 
 
Urinary Tract Infection
 
Urinary tract infection associated with  renal calculi, will be difficult to eradicate 
until the offending stones are completely removed.  Instead of SWL ,for these 
patients, PCNL or ureteroscopy, both of which permit the complete removal of 
stone fragments, may be preferable. Though  the reported incidence of sepsis after 
SWL is less than 1%,  a staghorn calculus increases this rate substantially to 2.7% 
to 56% (Lam et al
60
, 1992a). The risk of sepsis increases if the urine culture 
demonstrates bacterial growth before SWL (Zink
61
, 1988). Furthermore, presence 
of obstruction increases the risk of sepsis. Therefore, SWL should be advised and 
performed only if there is no distal obstruction and urine is sterile.  
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Morbid Obesity
 
Morbid obesity is defined as body mass index more than 40 or above 100 pounds 
or body weight more than 200%. In thesis cases success depend on the  physiologic 
and technical challenges. (Giblin et al, 1995
62
).  
 SWL is very difficult for morbid obesity patients  because of weight limitations on 
the lithotripter table or gantry, failure to target the stone radiographically, or the 
skin to stone distance will be more. If  the distance more between skin and stone 
which obstract the focus of  the shockwaves on the stone. A  point located  beyond 
F2 may be needed a blast path method which depend on high pressure (Whelan et 
al, 1988
63
; Locke et al, 1990
64
).   
 
BMI is a inverse relation and important factor for stone clearance  after ESWL 
(Ackermann et al, 1994
65
; Portis et al
66
, 2003).  
Stone-to-skin distance (SSD),  on CT, has been  popularized.it was reported by 
Perks
39
 (2008) that for SSD below or more than 9 cm , the success rate were  79% 
versus 57%  respectively.  
Pareek 
38
 (2005)  study showed 20% of success rate and 80% failure rate for SSD 
more than 10 cm.SSD was a better predictor of failure of treatment than the BMI.  
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In morbidly obese patients who have a complex renal calculus , PNL is the 
treatment of choice. For long SSD we can use extralong working sheath and rigid  
and flexy nephroscope which will help to overcome this problem.  
Ureteroscopic approach is usually used for morbidly obese patients  with low stone 
burden (Dash et al, 2002; Natalin et al, 2009). In morbid obese patients 
ureteroscopy does not have any extra morbidity. (Preminger et al, 2007). 
 
Spinal Deformity or Limb Contractures  
Using lithotripter it becomes very cumbersome to position patients with spinal 
problems and having contractures of limbs. 
In such patients we can go for PCNL and ureteroscopy with flexible instruments. 
 
Uncorrected Coagulopathy 
After  correcting  bleeding diathesis in uncorrected coagulopathy patients PCNL or 
SWL as a treatment is followed.  
Other Groups 
 The adverse effects of shockwaves will be increased when SWL is used for 
elderly,children ,hypertensive  and renal failure patients. to  overcome this problem 
we have to reduce the energy and number of shockwaves. (Janetschek et al
67
, 1997; 
Evan et al
68
, 1998; Lifshitz et al
69
, 1998). 
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Assessment and Fate of Residual Fragments 
In open surgery any size of the stone considered as failure but in ESWL clinically 
insignificant stones are considered as successful outcome which is best treatment 
for upper urinary tract calculi . (Newman et al
70
, 1988). 
After ESWL the stone clearance will take several days . 85% of the patients didn’t 
have  immediate clearance of stone fragments after SWL .The stone clearance is 
evidenced  by residual  of stone fragments caused by shockwaves (Drach et al
71
, 
1986).  
 
Eventhough  there will be spontaneous passage of stone fragments in the initial 3 
months there  will be a possibility of spontaneous  passing of  stones even after 24 
months of treatment.  (Chaussy and Schmiedt
72
, 1984; Graff et al
73
, 1988; 
Kohrmann et al
74
, 1993). Stone free rate and success rate have been used to define 
the outcome of ESWL treatment since it was introduced as a treatment for upper 
urinary tract calculi. Stone free rate means without any residual stone fragments 
but the success rate means a combination of  both clinically insignificant residual 
stone as well as stone free state. With the use of CT, ultrasound,KUB 
,nephrotomography we can find out clinically insignificant residual stones and 
stone free status make the comparison  difficult between  the outcome of  ESWL 
and endourological stone removal methods . 
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Stone size or diameter equal or less than 4 mm is considered as a successful 
outcome with other factors like sterile urine without any symptoms. (Newman et 
al
70
, 1988). Complete stone free state will reduce the risk of regrowth  and stone 
recurrence  (Singh et al
75
, 1975; Patterson et al
76
, 1987; Newman et al
70
, 1988). 
After ESWL if there are residual fragments ,then the recurrence rate is 17% to 80%  
but if stone free, the recurrence rate is only 6% to15%. (Graff et al
77
, 1988; Zanetti 
et al
78
, 1991; Nakamoto et al
79
, 1993). 
 
Extra Corporeal Shockwave Lithotripsy (ESWL)
 
Open surgeries for stone diseases are rarely done nowadays as they are replaced by 
minimally invasive and non invasive  various treatment procedures. Non-Invasive 
procedure like ESWL will produce minimal morbidity . 
Lithotripter is a Greek word .In Greek litho means stone and tripter means crusher. 
Lithotriptors have been evolved after many years of research in the physics of 
aviation. When a supersonic aircraft flies, the raindrops strike and creates 
shockwaves that disintegrates solid materials . Lithotripter was thus invented by 
making certain refinements from physics of flight, which will be useful for the 
treatment of urinary calculi.  
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Dr. Christian Chaussay 
72
, University of Munich first used electrically generated 
focused shockwaves  in  February 1980  to fragment the calculus inside the human 
kidney. 
The earliest Lithotriptor  model HM 1 was soon replaced by HM2 (1982) and  by 
HM 3( 1984)
14
 . Each such new  generation  attempts a progression of technology 
and a growing sophistication. Also further innovation of the generation is the 
amalgamation of the lithotripsy control and fluoroscopic screens into an  
efficient ,convenient,  and user friendly console. Lithotripsy technology has made 
great advances  in terms of focusing, patient coupling , shock wave generation and 
stone localization making it the ideal and  most widely used treatment for renal 
calculi
14
. 
 
VARIOUS METHODS OF SHOCK WAVE GENERATION 
Lithotriptor  Instruments  are differentiated  by the types of shockwave generators 
they employ. Modern day Commercially available lithotriptors use 
Electromagnetic (EM) Electrohydraulic (EH), and Piozoelectric generators
12
 . 
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ELECTRO HYDRAULIC (SPARK GAP) GENERATORS 
The mechanism involves  a spherically expanding shockwave  generated by an 
underwater spark discharge (15000-25000V) Electrode at F1 and focused by hemi 
ellipsoid reflector on to the calculus at F2
12
. Though it is very effective in breaking 
kidney stones ,substantial pressure fluctuations from shock to shock results in a 
relatively short electrode life. 
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ELECTROMAGNETIC GENERATORS 
EMSE - Electromagnetic shock wave Emitter. The components includes a disk coil 
which is charged with high voltage pulses (5000-20000V), by which, the 
membrane lying directly on the coil is thrust outwards
12
. An acoustic lens on the 
stone helps to focus the shock wave generated. 
The advantages
66
 of electromagnetic generator includes a better controllability and 
reproduciblity. It causes less pain because of the introduction of energy into 
patients body over a large skin area. The small focussing with high energy 
densities increases its effectiveness is breaking stones. Disadvantage is also due to 
the small focal concentration of high energy, resulting in increased rate of 
subcapsular hematoma formation. 
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PIEZOELECTRIC GENERATOR 
Piezoelectric energy source uses  piezoelectric crystals in a spherical array excited 
by an electric impulse of 2000-6000V  which results in simultaneous sudden 
expansion and shockwave generation
12
. The resultant waves are focused on to the 
stone. The advantages are precise focusing , anaesthesia free treatment and a long 
instrument life  . 
But the major disadvantage is the insufficient power it delivers, which hampers its 
ability to effectively break renal stones
66
. 
 
 
MECHANISMS OF VARYING STONE FRAGILITY 
Stone fragility is the main factor predicting the response of a renal calculus to 
SWL. This in turn varies with size ,composition  and structural features of stone
14
. 
Stones with homogenous architecture are less fragile than stones with 
heterogenous structure. Hardness determines a stone’s resistance to cavitation, 
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microjet impact and fracture. Toughness determines a stone’s resistance to spalling 
damage and crack propagation. Elastic module determines the stone’s resistance to 
shock wave induced deformation. COM(Calcium oxalate monohydrate) and 
brushite stones are less fragile than MAP(Magnesium ammonium phosphates) and 
CA(Carboxy apatite) stones because COM and brushite stones are harder, stiffer 
and more resistant to fracture
66
. 
 
MECHANISMS OF STONE FRAGMENTATION 
Stone fragmentation mechanisms are surface erosion at the anterior surface of 
stone, spalling damage at the posterior surface of stone and layer separation at the 
interface of adjacent stone laminar surface. Shock Waves are composed of both 
positive compressive waves and negative tensile waves. Shock waves create 
bubbles 100-200 ms size that collapse rapidly near the stone surface, producing 
high speed microjet (770 m/s) which impinges towards the stone surface to cause 
damage
12
. Numerous minute pits are formed on the anterior surface of stone which 
is the specific characteristic of cavitation induced surface erosion.  
Spalling damage separates the spherical cap from posterior surface of stone. This 
mechanism of stone damage can be attributed to the reflected tensile waves 
generated at the layer interface because of acoustic impedance mismatch between 
stone crystalline structure and surrounding matrix materials
66
. Multiple micro 
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fractures grow and propagate creating large crack lines leading to stone 
disintegration. 
Calculi maintain their form because of innate comprehensive forces. 
When tensile strength of a calculus is overcome by opposing force created by 
shockwaves, Fragmentation occurs. Stone fragmentation occurs by several 
mechanisms. 
The ultimate aim of ESWL is to fragment renal and ureteric calculi as much 
effectively as possible while  minimizing the potential injury to surrounding 
tissues.Stone fragmentation varies according to stone composition. Cystine stones 
are most resistant to ESWL
66
. Next in line are Brushite, and Calcium Oxalate 
Monohydrate.  
 
Bioeffects of ESWL 
Shock wave lithotripsy is associated with both acute renal injury and chronic renal 
changes. 
Tables1 and 2 highlight the Histologic features of acute and chronic changes, Risk 
factors and aggravating factors for acute renal injury and the mitigating factors for 
renal injury
68
 . Animal models have shown that ESWL can effect both acute and 
chronic histologic changes in kidney. Acute changes include cellular disruption 
and necrosis ,venous thrombi, tubular necrosis, parenchymal hemorrhage, rupture 
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of small veins and arteries, rupture of  glomerular and periglomerular capillaries
68
. 
Chronic histologic changes include dilated veins, fibrosis, nephron loss, calcium 
and hemosiderin deposits and hyalinised scars
68
. 
 
Table-1 - Acute Renal Side Effects: Risk Factors for Shockwave Lithotripsy 
 
Age 
Obesity 
Diabetes mellitus 
Preexisting hypertension 
 
Coronary heart disease 
Bleeding disorders 
Thrombocytopenia 
 
Table-2 Associated with Shockwave Lithotripsy 
Aggravating Factors 
Number of shocks 
Duration of shockwave administration—shorter period increases 
damage 
Accelerating voltage—higher the voltage more the damage 
Type of shockwave generator—first- vs. second/third-generation 
devices 
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Kidney size—juvenile vs. adult 
Preexisting renal impairment 
Mitigating Factors 
Pretreatment with 100 to 500 shocks at low energy level to reduce 
lesion size Treatment at a slow rate of shockwave delivery (60 shocks/min) 
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MATERIALS AND METHODS  
STUDY DESIGN 
This is a Prospective study of 100 Patients with upper tract stones treated with 
ESWL at Kilpauk Medical College Hospital, Chennai and Government Royapettah 
Hospital, Chennai from September 2012 to February 2014  
INCLUSION CRITERIA   
Upper urinary tract stones ≤ 2cms  
EXCLUSION CRITERIA  
Upper urinary tract stones > 2cms 
Pregnant women 
Bleeding diathesis 
Distal obstruction  
In all patients history and physical examination were done. Baseline investigations 
included Complete Haemogram, RFT, urine C/S, X-ray KUB, USG KUB, IVU 
and CT KUB. Stone location, stone size, calyceal anatomy and Hounsefield unit of 
the stone ,  presence of obstruction and hydronephrosis will be noted.  
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Bleeding profile (Platelet count, Bleeding time, Clotting time and Prothrombin 
time), Body mass index (BMI) will also be recorded for each patient . 
Patients were explained about the study, ESWL procedure and informed consent 
were obtained. ESWL was done as outpatient procedure at Rajiv Gandhi 
Government General Hospital, Chennai. ESWL was done using Dornier Compact 
Delta II (Electromagnetic Generator) Machine. Patients were administered sedation 
IV Fortwin (20mg), 30 minutes before procedure.  
Patients were followed up after 2 weeks and at 4 weeks, Xray KUB and USG KUB 
were done to look for residual fragment. Absence of calculi or calculi <4mm will 
be considered as clearance. 
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RESULTS 
Table 1: DescriptiveStatistics 
 SEX STONE SIZE HU LOCATION BMI 
N 
Valid 100 100 100 100 100 
Missing 0 0 0 0 0 
Mean  1.539 769.68  23.86 
Median  1.600 760.00  23.50 
Std. Deviation  .3856 183.421  3.065 
Minimum  .7 400  18 
Maximum  2.0 1300  31 
Table 2: Age Group*Stone Clearance Crosstab 
   outcome  
   0 1 Total 
AGE GROUP <=30 Count 14 6 20 
% within outcome 22.6% 15.8% 20.0% 
% of Total 14.0% 6.0% 20.0% 
31-40 Count 16 15 31 
% within outcome 25.8% 39.5% 31.0% 
% of Total 16.0% 15.0% 31.0% 
41-50 Count 18 10 28 
% within outcome 29.0% 26.3% 28.0% 
% of Total 18.0% 10.0% 28.0% 
>50 Count 14 7 21 
% within outcome 22.6% 18.4% 21.0% 
% of Total 14.0% 7.0% 21.0% 
 Total Count 62 38 100 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
Chi-Square P Value 0.528 
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Chart 1: Age Group*Outcome   
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Table 3: Sex Distribution 
 Frequency Percent Valid Percent Cumulative Percent 
Valid 
F 48 48.0 48.0 48.0 
M 52 52.0 52.0 100.0 
Total 100 100.0 100.0  
 
Chart 2: Sex Distribution  
 
 
Table 4: Sex*Outcome Crosstab 
 outcome Total 
0 1 
SEX 
F 
Count 27 21 48 
% within SEX 56.2% 43.8% 100.0% 
% within outcome 43.5% 55.3% 48.0% 
% of Total 27.0% 21.0% 48.0% 
M 
Count 35 17 52 
% within SEX 67.3% 32.7% 100.0% 
% within outcome 56.5% 44.7% 52.0% 
% of Total 35.0% 17.0% 52.0% 
Total 
Count 62 38 100 
% within SEX 62.0% 38.0% 100.0% 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
Chi-Square P value 0.255. 
48 
52 
F 
M 
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Table 5: BMI*Outcome Crosstab 
   outcome  
   0 1 Total 
BMI <25 Count 44 17 61 
% within outcome 71.0% 44.7% 61.0% 
% of Total 44.0% 17.0% 61.0% 
25-30 Count 18 16 34 
% within outcome 29.0% 42.1% 34.0% 
% of Total 18.0% 16.0% 34.0% 
>30 Count 0 5 5 
% within outcome .0% 13.2% 5.0% 
% of Total .0% 5.0% 5.0% 
 Total Count 62 38 100 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
 
Chi-Square P value 0.002 
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Chart 3: BMI*Outcome 
 
 
Table 6: Stone Size*Outcome 
 outcome Total 
0 1 
Sizestone 
<1.5 
Count 27 11 38 
% within Sizestone 71.1% 28.9% 100.0% 
% within outcome 43.5% 28.9% 38.0% 
% of Total 27.0% 11.0% 38.0% 
>=1.5 
Count 35 27 62 
% within Sizestone 56.5% 43.5% 100.0% 
% within outcome 56.5% 71.1% 62.0% 
% of Total 35.0% 27.0% 62.0% 
Total 
Count 62 38 100 
% within Sizestone 62.0% 38.0% 100.0% 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
 
Student T test P Value 0.020 
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Chart 4: Stone Size*outcome 
 
 
 
 
Table 7: HU*Outcome Crosstab 
 Outcome Total 
0 1 
Hounsfieldunits 
<=750 
Count 38 9 47 
% within Hounsfieldunits 80.9% 19.1% 100.0% 
% within outcome 61.3% 23.7% 47.0% 
% of Total 38.0% 9.0% 47.0% 
>750 
Count 24 29 53 
% within Hounsfieldunits 45.3% 54.7% 100.0% 
% within outcome 38.7% 76.3% 53.0% 
% of Total 24.0% 29.0% 53.0% 
Total 
Count 62 38 100 
% within Hounsfieldunits 62.0% 38.0% 100.0% 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
 
Student T test P Value 0.000. 
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Chart 5: HU*Outcome 
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Table 8: Location*Outcome Crosstab 
 outcome Total 
0 1 
LOCATION 
LOWER CALYX 
Count 7 22 29 
% within LOCATION 24.1% 75.9% 100.0% 
% within outcome 11.3% 57.9% 29.0% 
% of Total 7.0% 22.0% 29.0% 
MID CALYX 
Count 18 6 24 
% within LOCATION 75.0% 25.0% 100.0% 
% within outcome 29.0% 15.8% 24.0% 
% of Total 18.0% 6.0% 24.0% 
PELVIS 
Count 17 6 23 
% within LOCATION 73.9% 26.1% 100.0% 
% within outcome 27.4% 15.8% 23.0% 
% of Total 17.0% 6.0% 23.0% 
UPPER CALYX 
Count 16 4 20 
% within LOCATION 80.0% 20.0% 100.0% 
% within outcome 25.8% 10.5% 20.0% 
% of Total 16.0% 4.0% 20.0% 
UPPER URETER 
Count 4 0 4 
% within LOCATION 100.0% 0.0% 100.0% 
% within outcome 6.5% 0.0% 4.0% 
% of Total 4.0% 0.0% 4.0% 
Total 
Count 62 38 100 
% within LOCATION 62.0% 38.0% 100.0% 
% within outcome 100.0% 100.0% 100.0% 
% of Total 62.0% 38.0% 100.0% 
 
 Chi-Square P Value 0.000 
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Chart 6: Location*Outcome 
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LOGISTIC REGRESSION 
   
Coefficients and Standard Errors 
   
Variable Coefficient Std. Error P 
BMI 0.21417 0.099675 0.0317 
LOCATION 3.14933 0.70954 <0.0001 
HU 0.0082171 0.0024829 0.0009 
Constant -13.1626     
   
 
 
Odds Ratios and 95% Confidence Intervals  
   
Variable Odds ratio 95% CI 
BMI 1.2388 1.0190 to 1.5061 
LOCATION 23.3205 5.8045 to 93.6936 
HU 1.0083 1.0034 to 1.0132 
   
 
Hosmer & Lemeshow test 
   
Chi-square 5.6900 
DF 8 
Significance level P = 0.6819 
   
 
51 
 
Contingency table for Hosmer & Lemeshow test [Hide] 
   
Group 
Y=0 Y=1 
Total 
Observed Expected Observed Expected 
1 10 9.882 0 0.118 10 
2 11 10.547 0 0.453 11 
3 9 9.325 1 0.675 10 
4 8 8.751 2 1.249 10 
5 8 7.916 2 2.084 10 
6 8 6.746 2 3.254 10 
7 2 4.435 8 5.565 10 
8 4 2.847 6 7.153 10 
9 2 1.321 8 8.679 10 
10 0 0.230 9 8.770 9 
   
   
ROC curve analysis 
   
Area under the ROC curve (AUC)  0.901 
Standard Error 0.0307 
95% Confidence interval 0.825 to 0.952 
   
  
Save predicted probabilities - Save residuals 
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ROC curve 
Variable LOGREGR_Pred1 
Classification variable outcome 
   
Sample size   100 
Positive group :  outcome = 1 38 
Negative group :  outcome = 0 62 
   
Disease prevalence (%) unknown 
   
Area under the ROC curve (AUC)  
   
Area under the ROC curve (AUC)  0.900891 
Standard Error
a
 0.0308 
95% Confidence interval
b
 0.824862 to 0.951629 
z statistic 13.033 
Significance level P (Area=0.5) <0.0001 
a
 DeLong et al., 1988 
b
 Binomial exact 
   
Youden index 
   
Youden index J 0.7071 
Associated criterion >0.3247 
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Criterion values and coordinates of the ROC curve [Hide] 
   
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR 
>0.3247 86.84 71.9 - 95.6 83.87 72.3 - 92.0 5.38 0.16 
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SUMMARY OF RESULTS 
 
 100 patients were included in this analytical  study 
 Statistical analysis was done using  SPSS  software version  20 and  
MEDCALC.  
 Univariate analysis for various risk factors influencing the outcome of  
ESWL was done.  
 Logistic regression model using multiple variable was done to calculate 
ROC curve. 
  This study included 100 patients, falling in the age group of 19 to 74 years 
with a mean age of 40.74 years. 
 Age as an independent factor did not significantly correlate to the outcome 
of ESWL (p value 0.528). 
 The next factor considered was the sex of the patient in relation to the 
outcome of ESWL. In this study there were 52 male patients and 48 female 
patients. 
 Sex of the patient  as a univariate factor also did not correlate significantly to 
the success  of  ESWL (p value 0.255). 
 BMI of the study group was classified into three groups { < 25(61 patients), 
25-30(34 patients) and  > 30(5 patients)}. The rate of successful ESWL in 
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these groups were   72%, 52.9% and 0% respectively. The P value according 
to the Chi square test was 0.002 which showed a significant correlation of 
BMI with regard to the outcome of ESWL. 
 The fourth factor studied was the size of the stone in predicting the outcome 
of ESWL. The patients were divided into two groups based on the stone size 
(< 1.5cm and ≥ 1.5). 
 38 patients had stone size < 1.5 cm. This particular group showed a 
successful outcome of 71%. 62 patients had stone size ≥ 1.5 cm with a  
success rate  of 56% which correlated significantly to the outcome of ESWL 
(p value using T-test 0.020).  
 The  fifth factor analysed was the density of the stone as assessed by the 
Hounsefield Units. 
 Patients were classified under two categories based on HU value of less or 
greater than 750 HU. 47 patients had stones with HU less than 750. 80.9%  
of these patients had a successful outcome of ESWL. The remaining 53 
patients had HU more than 750.They had a significantly reduced success 
rate of 45.3% (p value using T-test- 0.000). 
 The next factor considered in the study was the location of the stone in 
relation to the outcome of ESWL. 
 Patients were divided into five groups based on whether the stone was 
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situated in the upper, middle, lower calyx, renal pelvis or upper ureter.  
 29 patients had lower calyceal stone and 24.1% had a successful outcome in 
this group following ESWL. 
 23 patients had a stone in renal pelvis and 73.9% had a successful outcome. 
 24 patients had stone in middle calyx with a 75% successful outcome. 
 20 patients had a stone in the upper calyx and 80% of these patients had a 
successful outcome.  
 4 patients had a stone in the upper ureter and all had a successful outcome. 
  This proved conclusively that the location of the stone as an independent 
factor can significantly predict the positive  negative outcome of ESWL, the 
upper ureteric stones having the best prognosis and the lower calyceal stones 
having the least successful outcome ( P value using chi-square tests – 0.000).  
 Model for multivariate analysis was done using logistic regression analysis 
to create an ROC curve. 
 The factors included in this model were BMI, location and Stone density to 
predict the outcome following ESWL in upper urinary tract stones < 2 cms. 
Location of the stone was the most significant factor in this model (p value 
<0.0001). The model derived has a sensitivity and specificity of 86.8% and 
83.9% respectively in predicting the success rate following ESWL. 
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DISCUSSION 
 
       The ultimate goal of any modality of treatment of upper urinary tract stones is  
to achieve a 100% stone clearance without causing any morbidity to the patient. 
The current treatment modalities include percutaneous nephrolithotomy (PCNL), 
extracorporeal shock wave lithotripsy (ESWL), retrograde intrarenal surgery 
(RIRS) and in rare cases laparoscopic or open stone surgery. ESWL being a non-
invasive technique has added an important dimension to the treatment of stone 
disease wherein the vast majority of small calculi within the renal system (80 - 
85%) can be managed satisfactorily. 
        ESWL is the preferred modality of treatment for renal stones less than 2cm. 
However stone free rate (SFR) after treatment has never been near 100% and has 
been in the range of 65-75%. But its non invasive nature along with high efficacy 
has resulted in outstanding patient and surgeon acceptance. 
        Factors  affecting stone clearance can be classified into to stone factors (size, 
composition, number, location), renal factors pertaining to anatomy and factors 
related to the patient.  
        BMI >30 is a significant factor affecting the success of treatment of upper 
tract stones. The utility of BMI in predicting successful ESWL is variable. 
      Pareek et al
38
 studied the effect of BMI on stone clearance rates. An increased 
BMI was associated with poor outcomes, which was comparable to this study. 
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     Thomas  & Cass 
29
 also reported  an overall stone free rate of 68%  in obese 
patients compared to 80 - 85% in non-obese patients. In the contrary, Hammad 
Ather et al 
30
 did not find BMI to be a predictor for ESWL outcome. 
          Size of the stone was one of the most important factors determining success 
of  ESWL. Stone size was a significant predictor of a favourable outcome in this  
study  with 71% success reported for stones <1.5cms and 56% for stones >1.5cms. 
          Khalil et al
34
 in their analysis of stone free rates after ESWL based on stone 
location and stone size reported stone free rates for stones less than 1 cm, 1-2 cm, 
and more than 2 cm at 50.2, 39.6, and 10.2% (P  < .05) respectively.  
       Abdel-Khalek et al
35
 reported stone free rate as 89.7%for stones <15 mm and 
78% for stones >15 mm (p<0.0001). 
        Lalaket al
32
  in their series reported an overall stone-free rate of 76%, 66% 
and 47% for stones of size less than 10 mm, 10 to 20 mm and more than 20 mm 
respectively.   Newman D et al
33
 in their study  found than success rate was 80% 
with 0-10 mm stones whereas it declined to 60% with size of the stone greater than 
30 mm. 
           All the above studies concluded that size of the stone was one of the most 
important predictive factor for successful outcome of ESWL. 
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             Stone density has an inverse relation with the ESWL success rate, and CT 
stone density has a positive correlation with the number of shockwaves needed for  
fragmentation as concluded from various studies. 
               Gupta et al
37
 showed that the worst outcome of ESWL was in patients 
with calculus densities of more than 750 Hounsfield units and diameters of more 
than 1.1 cms, and their clearance rate was only 60% while it was  90% for densities 
below 750 . 
                  Ouzaid et al 
40
 in a prospective  study concluded that patients who 
became stone free or had clinically insignificant stone fragments had a lower 
density compared with stones in patients with residual fragments [mean (SD) 715 
(260) vs. 1196 (171) HU, P < 0.001]. 
                Perks et al
39
  in his study on the role of ESWL  for a solitary renal stone 
of 5–20 mm found  the stone attenuation of the successfully treated patients (stone 
free and complete fragmentation groups) was 837 +/- 277 versus 1092 +/-254 HU 
for those with treatment failure (incomplete fragmentation; P < 0.01). 
               Pareek et al
38
 in another  prospective study found  the difference in the 
mean HU values for the stone-free patients was 577.8 +/- 182.5 and residual stones 
groups were statistically significant (910.4 +/-190.2). 
                 Joseph et al
36
  reported a 95% success rate for calculi ＜1,000 HU vs. 
55% for stones ＞1,000 HU (p＜0.01).        . 
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           The rate of disintegration for stones in the lower calyx treated by ESWL is 
comparable with stones in other locations within the urinary tract. But the spatial 
anatomy of the lower calyx in unfavourable for the  complete clearance of the 
fragments.  
          Obek et al
44
  in their study about patients with isolated lower pole calculi 
treated with  ESWL reported a stone-free rate of 63%. 
         Chen and Streem
45
 reported a stone-free rate at 1 month following ESWL 
was 48% and a longer-term stone-free rate after ESWL was 54.3% with isolated 
lower pole calculi . 
          In a study by Lingeman et al
46
 the limitations of ESWL for lower pole 
stones are highlighted. Patients who underwent ESWL were reviewed and the 
result was a poor overall stone clearance rate of 60% against 90% for PCNL. 
Furthermore, higher re-treatment rate was observed when comparing the lower 
calyx with other intrarenal locations. Successful outcomes for stones measuring 
less than 10 mm, 10-20 mm and more than 20 mm were 74%, 56%, and 33%, 
respectively. 
         Netto and coworkers
47
   in their study had an overall success rate of 79% for 
lower calyceal stones. The success rates were 78% for stones <10 mm, 85% for 
stones measuring 11-20 mm and 50% for stones measuring  >20 mm.  
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           Talic and El Faqih
43
 had a 56% stone free rate for all lower calyceal calculi 
3 months following ESWL. 
           However , Psihramis and colleagues
48
   reported a higher success rate for 
lower-caliceal (53%) than for middle- (43%) and upper- (45%) caliceal stones.   
        Öbek and associates
44
  in their study reported stone-free rate of 71% for 
upper,  73% for middle and 63% for lower caliceal stones. 
      Graff and colleagues
49
 had similar results, with stone-free rates of 78%, 76%, 
and 58% for upper pole, Middle and lower pole calculi. 
 stones residing in upper pole calyces, as well as the renal pelvis and ureteropelvic 
junction, are associated with the best stone-free rates when treated by SWL.  
      An analysis was done considering 9 different published series on the 
management of 8000 stones with ESWL. The stone-free rates for renal pelvic 
stones varied from 80% for stones measuring less than 10 mm to 56% for larger 
stones. 
    Pace et al
51
 reported a significantly better response to shock wave application in 
Proximal and midureteric stones than to those  in the distal ureter. 
    Park et al
52
 managed 301 patients with upper ureteral stones with ESWL. The 
success rate achieved was 84.3% for stones < 10 mm after a single session. The 
results for stones measuring > 20 mm were not comparable. The average stone size 
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in the group treated successfully was 12 mm in comparison to 17 mm in the group 
that required ancillary treatment. 
       ESWL was successful for upper ureteral stones < 10 mm in various series.  
The 1997 AUA Ureteral Stone Clinical Guidelines
53
 recommend ESWL as the first 
line of management for stones <1cm in the proximal ureter, while the ideal 
treatment for stones > 1 cm still is debatable with both ESWL and ureteroscopy 
being acceptable options. 
       The results of treatment for proximal ureteral calculi either in situ or after stent 
placement range from 57 to 96% with a high re-treatment rate of 5 to 60% .  
All these authors were of common opinion that location of the stone was one of the 
most important  predictive factor for successful outcome of ESWL.   In this study 
lower pole calyceal stone clearance was significantly less than that of stones in 
other locations and is comparable to the above studies.  
 
 
 
 
 
 
 
63 
 
CONCLUSION 
ESWL  is a useful, non invasive modality of treating certain types of upper urinary 
tract calculi. 
The overall success rate of ESWL in this study was 62 % in treating upper urinary 
tract calculi. 
The prognostication of the success of ESWL is possible by identifying certain 
factors which enable us to easily select the patient group for whom this treatment 
can be given. 
Age and sex of the patient have no role in predicting the successful outcome of 
ESWL. 
BMI of the patient had a significant inverse correlation with successful outcome of 
ESWL. 
Calculi with lesser density( HU<750) and smaller size(<1.5cm) have a better 
success rates with ESWL. 
Calculi of the upper ureter,upper,milddle calyces and renal pelvis had a good 
response rate to ESWL when compared to lower pole calculi. 
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ANNEXURE - 1 
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ANNEXURE - 2 
PROFORMA 
Name:     Age:     Sex:   
  
KMC/GRH:    I.P No:    Date: 
Complaints: 
Loin pain: 
Frequency: 
Urgency: 
Hematuria: 
Calcaluria: 
Fever:  
Examination: 
General Examination: pallor: 
Height:    weight:   B.M.I: 
P/A 
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Investigations: 
Hb:    TC:    DC: 
RBS:    Urea:    Creatinine: 
Urine: Alb 
 Sugar  
 Deposits 
Urine C/S: 
X-Ray KUB: 
 
USG: 
IVU: 
CT-KUB: 
ESWL: 
Shockwave frequency: 
Fragmentation: 
Residual Calculus: 
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